The findings could also, hypothetically be explained by less exposure to hypoglycaemic episodes in people with type 1 diabetes due to improvement of insulin therapy and use of CGM, compared to earlier studies and warrants further investigation. This evidence concerns the gene INS and type 1 diabetes mellitus.